EPISODE · Dec 1, 2022 · 9 MIN
For Alzheimer’s Scientists, the Amyloid Debate Has No Easy Answers
from Science, Spoken · host WIRED
For years, potential therapies that attack this brain protein have failed to help patients in clinical trials. Now—surprisingly—a new drug shows promise. Learn more about your ad choices. Visit podcastchoices.com/adchoices
What this episode covers
For years, potential therapies that attack this brain protein have failed to help patients in clinical trials. Now—surprisingly—a new drug shows promise. Learn more about your ad choices. Visit podcastchoices.com/adchoices
NOW PLAYING
For Alzheimer’s Scientists, the Amyloid Debate Has No Easy Answers
No transcript for this episode yet
Similar Episodes
No similar episodes found.